Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,9213,940 of 20,252 grants

Active TRAINING, INDIVIDUAL
Hypoxic regulation of macrophage migration and function via fibroblast reprogramming in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2027

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the United States despite representing only 2% of all cancer cases. P...

$420.9K
USD
Active TRAINING, INDIVIDUAL
Regulation of hematopoiesis during tumor progression
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

Project Summary/Abstract The immune system plays an important role during tumor progression, having the ability to recognize and kill tumor cells (T cells and NK cells) [1]. Unfort...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2023 – 2026

Abstract While a growing arsenal of drugs is available to treat specific molecular abnormalities across cancers, therapy effectiveness can now be predicted by detecting specific ge...

$3.6M
USD
Active NON-SBIR/STTR RPGS
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Abstract Aggressive malignant progression and spreading has limited a clear understanding of the pathophysiology of SCLC. The overarching goal of this “bedside to bench” project is...

$3.67M
USD
Active NON-SBIR/STTR RPGS
Engineering Protein Modulators of Notch Activation for T-cell immunotherapy
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2026

Summary Investigators at the University of Minnesota have teamed up to engineer novel protein activators of the Notch family of cell surface receptors, which are master regulators...

$3.66M
USD
Active NON-SBIR/STTR RPGS
Advanced Sample Preparation, Separation and Multiplexed Analysis for In-Depth Proteome Profiling of >1000 Single Cells Per Day
NATIONAL CANCER INSTITUTE Brigham Young University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Cancer tissues exhibit a high degree of phenotypic heterogeneity and plasticity and contain numerous subpopulations of cells in various states. Quantifying...

$5.18M
USD
Active NON-SBIR/STTR RPGS
Development and Implementation of Advanced Technologies for Cancer Metabolism Research
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2023 – 2028

PROJECT SUMMARY This proposal requests support for my position as the Director of the Cancer Metabolism Core at Sanford Burnham Prebys Medical Discovery Institute (SBP). The Core i...

$1.42M
USD
Active NON-SBIR/STTR RPGS
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is particularly resistant to therapy and typically presents as metastatic disease. Characterized by hypoxia, dense stroma, and meta...

$753.6K
USD
Active RESEARCH CENTERS
The role of ARID1A mutations in Latino gastric cancer biology and disparities
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The University of California and the University of Texas Southwestern (UCaTS) Diversity Patient-Derived Xenograft (PDX) Development and Trial Center’s is a...

$884.4K
USD
Active RESEARCH CENTERS
Cancer biology and pre-clinical studies of BRCAness in Latino gastric tumors
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The University of California and the University of Texas Southwestern (UCaTS) Diversity Patient-Derived Xenograft (PDX) Development and Trial Center’s is a...

$1.3M
USD
Active NON-SBIR/STTR RPGS
Personalized neoantigen vaccines using nucleoside-modified mRNA-lipid nanoparticles
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2023 – 2028

PROJECT SUMMARY: U01 CA217959 Supplement Application This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-029. The pare...

$1.78M
USD
Active NON-SBIR/STTR RPGS
Immunoregulatory Mechanisms of BiTE Efficacy in the Cold Neuroblastoma TME
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2023 – 2028

ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-24-029. Bispecific T cell engagers (BTE) connect cancer cells...

$1.96M
USD
Completed SBIR-STTR RPGS
Targeting Macrophages to Treat Soft Tissue Sarcomas
NATIONAL CANCER INSTITUTE Resolute Science, Inc United States 2023 – 2026

PROJECT SUMMARY Soft tissues sarcomas (STS) is a broad term for multiple subtypes of cancer that start in soft tissues. Most STS are treated in the same way in the clinic regardles...

$7.27M
USD
Active NON-SBIR/STTR RPGS
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2023 – 2028

ABSTRACT Targeted cancer therapy, in the form of tyrosine kinase inhibitors, has been a game changer for patients with cancers driven by activating mutations in genes encoding thes...

$1.92M
USD
Active NON-SBIR/STTR RPGS
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2023 – 2028

ABSTRACT Targeted cancer therapy, in the form of tyrosine kinase inhibitors, has been a game changer for patients with cancers driven by activating mutations in genes encoding thes...

$2.03M
USD
Active SBIR-STTR RPGS
Tumor Monorail Device for Serial Glioblastoma Biopsy
NATIONAL CANCER INSTITUTE Exvade Bioscience, Inc United States 2023 – 2026

Project Summary/Abstract Glioblastoma (GBM) is one of the most common and deadliest form of malignant brain tumors, with median patient survival of 12-15 months and five-year survi...

$9.99M
USD
Completed NON-SBIR/STTR RPGS
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2025

PROJECT SUMMARY Cancer among Adolescents and Young Adults (AYAs) is particularly difficult because age-related developmental challenges of identity, relationships, and vocation may...

$3.52M
USD
Active NON-SBIR/STTR RPGS
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Priming of antitumor immunity relies on a specialized subset of conventional Dendritic Cells (cDC1s), CD103+ DCs, that have unique capabilities of trafficking tumor antigens to lym...

$3.78M
USD
Active NON-SBIR/STTR RPGS
Exploiting cell fate transition to overcome radiation resistance in glioblastoma
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2023 – 2028

PROJECT SUMMARY Glioblastoma (GBM) is a devastating brain tumor that affects about 15,000 Americans every year. Despite maximal surgical resection and chemoradiation, GBMs remain i...

$7.1M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of tumor cell clustering in breast cancer metastasis
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2028

Metastasis is the primary cause of breast cancer-related morbidity and mortality. During metastasis, cells from primary tumors shed into the bloodstream as circulating tumor cells...

$4.63M
USD